The goal of this book is to review the current status of the field of lipid signaling focused on translational significance / inhibitors with the prospect to be clinically relevant for human disease

The book combines both basic principles and applied agents with clinical significance for lipid cell signaling, phospholipases and lipid kinases, lipid metabolism and trafficking, and bioactive lipids, creating a volume broad enough to attract a wide readership

Drug development and novel application ideas, such as enzyme inhibitors or receptors antagonists in preclinical or current clinical trials are incorporated where possible